Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Oct 17;10(10):CD008310.
doi: 10.1002/14651858.CD008310.pub2.

Nebulised surfactant in preterm infants with or at risk of respiratory distress syndrome

Mohamed E Abdel-Latif  1 , David A Osborn
Affiliations

Nebulised surfactant in preterm infants with or at risk of respiratory distress syndrome

Mohamed E Abdel-Latif et al. Cochrane Database Syst Rev. .

Abstract

Background: Nebulised surfactant has the potential to deliver surfactant to the infant lung with the goal of avoiding endotracheal intubation and ventilation, ventilator-induced lung injury and bronchopulmonary dysplasia (BPD).

Objectives: To determine the effect of nebulised surfactant administration either as prophylaxis or treatment compared to placebo, no treatment or intratracheal surfactant administration on morbidity and mortality in preterm infants with, or at risk of, respiratory distress syndrome (RDS).

Search methods: Searches were performed of CENTRAL (The Cochrane Library, January 2012), MEDLINE and PREMEDLINE (1950 to January 2012), EMBASE (1980 to January 2012) and CINAHL (1982 to January 2012), as well as proceedings of scientific meetings, clinical trial registries, Google Scholar and reference lists of identified studies. Expert informants and surfactant manufacturers were contacted.

Selection criteria: Randomised, cluster-randomised or quasi-randomised controlled trials of nebulised surfactant administration compared to placebo, no treatment, or other routes of administration (laryngeal, pharyngeal instillation of surfactant before the first breath, thin endotracheal catheter surfactant administration or intratracheal surfactant instillation) on morbidity and mortality in preterm infants at risk of RDS. We considered published, unpublished and ongoing trials.

Data collection and analysis: Two review authors independently assessed studies for eligibility and quality, and extracted data.

Main results: No studies of prophylactic or early nebulised surfactant administration were found. A single small study of late rescue nebulised surfactant was included. The study is of moderate risk of bias. The study enrolled 32 preterm infants born < 36 weeks' gestation with RDS on nasal continuous positive airway pressure (nCPAP). The study reported no significant difference between nebulised surfactant administration compared to no treatment groups in chronic lung disease (risk ratio (RR) 5.00; 95% confidence interval (CI) 0.26 to 96.59) or other outcomes (oxygenation 1 to 12 hours after randomisation, need for mechanical ventilation, days of mechanical ventilation or continuous positive airways pressure (CPAP) or days of supplemental oxygen). No side effects of the nebulised surfactant therapy or aerosol inhalation were reported.

Authors' conclusions: There are insufficient data to support or refute the use of nebulised surfactant in clinical practice. Adequately powered trials are required to determine the effect of nebulised surfactant administration for prevention or early treatment of RDS in preterm infants. Nebulised surfactant administration should be limited to clinical trials.

PubMed Disclaimer

Conflict of interest statement

None known.

Figures

1.1
1.1. Analysis
Comparison 1 Treatment of RDS with nebulised surfactant versus no treatment, Outcome 1 Chronic lung disease.
1.2
1.2. Analysis
Comparison 1 Treatment of RDS with nebulised surfactant versus no treatment, Outcome 2 Mechanical ventilation.
1.3
1.3. Analysis
Comparison 1 Treatment of RDS with nebulised surfactant versus no treatment, Outcome 3 Air leak.
1.4
1.4. Analysis
Comparison 1 Treatment of RDS with nebulised surfactant versus no treatment, Outcome 4 Patent ductus arteriosus.
1.5
1.5. Analysis
Comparison 1 Treatment of RDS with nebulised surfactant versus no treatment, Outcome 5 Pathological cerebral ultrasound at 1 week.
See this image and copyright information in PMC

Update of

  • doi: 10.1002/14651858.CD008310

References

References to studies included in this review

Berggren 2000 {published data only}
    1. Berggren E, Liljedahl M, Winbladh B, Andreasson B, Curstedt T, Robertson B, et al. Pilot study of nebulized surfactant therapy for neonatal respiratory distress syndrome. Acta Paediatrica 2000;89(4):460‐4. - PubMed

References to studies excluded from this review

Arroe 1998 {published data only}
    1. Arroe M, Pedersen‐Bjergaard L, Albertsen P, Bode S, Greisen G, Jonsbo F. Inhalation of aerosolized surfactant Exosurf® to neonates treated with nasal continuous positive airway pressure. Prenatal and Neonatal Medicine 1998;3(3):346‐52.
Finer 2010 {published data only}
    1. Finer NN, Merritt TA, Bernstein G, Job L, Mazela J, Liu G. A multicenter pilot study of AerosurfTM delivered via nasal continuous positive airway pressure (nCPAP) to prevent respiratory distress syndrome in preterm neonates. Proceeding of the 2006 Pediatric Academic Societies Annual Meeting. San Francisco, CA, USA. Pediatric Research. 2006; Vol. 59:4840.138.
    1. Finer NN, Merritt TA, Bernstein G, Job L, Mazela J, Segal R. An open label, pilot study of Aerosurf® combined with nCPAP to prevent RDS in preterm neonates. Journal of Aerosol Medicine and Pulmonary Drug Delivery 2010;23(5):303‐9. - PubMed
Jorch 1997 {published data only}
    1. Jorch G, Hartl H, Roth B, Kribs A, Gortner L, Schaible T, et al. Surfactant aerosol treatment of respiratory distress syndrome in spontaneously breathing premature infants. Pediatric Pulmonology 1997;24(3):222‐4. - PubMed
    1. Jorch G, Weller E, Murlat A, Hentschel R. Feasibility study on nebulization of bovine surfactant (SF‐RI 1) by pharyngeal continuous positive airway pressure (CPAP). Biology of the Neonate 1994;66:166.
Pearson 2005 {published data only}
    1. Pearson R, Pippins M, Niven R, Johnson ME. Treatment of RDS using aerosolized KL4 lung surfactant in combination with nCPAP. Proceeding of the 2005 European Society for Pediatric Research Annual Meeting. Siena, Italy. Pediatric Research. 2005; Vol. 58(2):386.

Additional references

Allen 2003
    1. Allen J, Zwerdling R, Gaultier C, Geggel R, Greenough A, Kleinman R, et al. Statement on the care of the child with chronic lung disease of infancy and childhood. American Journal of Respiratory and Critical Care Medicine 2003;168(3):356‐96. - PubMed
Aly 2001
    1. Aly HZ. Nasal prongs continuous positive airway pressure: a simple yet powerful tool. Pediatrics 2001;108(3):759‐61. - PubMed
Aly 2008
    1. Aly H, Badawy M, El‐Kholy A, Nabil R, Mohamed A. Randomized, controlled trial on tracheal colonization of ventilated infants: can gravity prevent ventilator‐associated pneumonia?. Pediatrics 2008;122(4):770‐4. - PubMed
Arzhavitina 2010
    1. Arzhavitina A, Steckel H. Surface active drugs significantly alter the drug output rate from medical nebulizers. International Journal of Pharmaceutics 2010;384:128‐136. - PubMed
Bahlmann 2000
    1. Bahlmann H, Sun B, Nilsson G, Curstedt T, Robertson B. Aerosolized surfactant in lung‐lavaged adult rats: factors influencing the therapeutic response. Acta Anaesthesiologica Scandinavica 2000;44(5):612‐22. - PubMed
Bell 1978
    1. Bell MJ, Ternberg JL, Feigin RD, Keating JP, Marshall R, Barton L, et al. Neonatal necrotizing enterocolitis. Therapeutic decisions based upon clinical staging. Annals of Surgery 1978;187(1):1‐7. - PMC - PubMed
Björklund 1997
    1. Björklund LJ, Ingimarsson J, Curstedt T, John J, Robertson B, Werner O, et al. Manual ventilation with a few large breaths at birth compromises the therapeutic effect of subsequent surfactant replacement in immature lambs. Pediatric Research 1997;42(3):348‐55. - PubMed
Bohlin 2007
    1. Bohlin K, Gudmundsdottir T, Katz‐Salamon M, Jonsson B, Blennow M. Implementation of surfactant treatment during continuous positive airway pressure. Journal of Perinatology 2007;27(7):422‐7. - PubMed
Chye 1995
    1. Chye JK, Gray PH. Rehospitalization and growth of infants with bronchopulmonary dysplasia: a matched control study. Journal of Paediatrics and Child Health 1995;31(2):105‐11. - PubMed
Clark 2000
    1. Clark RH, Slutsky AS, Gerstmann DR. Lung protective strategies of ventilation in the neonate: what are they?. Pediatrics 2000;105(1 Pt 1):112‐4. - PubMed
Coalson 1999
    1. Coalson JJ, Winter VT, Siler‐Khodr T. Neonatal chronic lung disease in extremely immature baboons. American Journal of Respiratory and Critical Care Medicine 1999;160(4):1333‐6. - PubMed
Cole 2000
    1. Cole C. Special problems in aerosol delivery: neonatal and pediatric considerations. Respiratory Care 2000;45(6):646‐51. - PubMed
Dargaville 2011
    1. Dargaville PA, Aiyappan A, Cornelius A, Williams C, Paoli AG. Preliminary evaluation of a new technique of minimally invasive surfactant therapy. Archives of Disease in Childhood Fetal and Neonatal Edition 2011;96:F243‐8. - PubMed
Davis 2008
    1. Davis PG, Lemyre B, Paoli AG. Nasal intermittent positive pressure ventilation (NIPPV) versus nasal continuous positive airway pressure (NCPAP) for preterm neonates after extubation. Cochrane Database of Systematic Reviews 2008, Issue 2. [DOI: 10.1002/14651858.CD003212] - DOI - PubMed
DeKlerk 2001
    1. DeKlerk AM, DeKlerk RK. Use of continuous positive airway pressure in preterm infants: comments and experience from New Zealand. Pediatrics 2001;108(3):761‐2. - PubMed
Doyle 2006
    1. Doyle LW, Victorian Infant Collaborative Study Group. Respiratory function at age 8–9 years in extremely low birthweight/very preterm children born in Victoria in 1991–1992. Pediatric Pulmonology 2006;41(6):570‐6. - PubMed
Dunn 2011
    1. Dunn MS, Kaempf J, Klerk A, Klerk R, Reilly M, Howard D, et al. Randomized trial comparing 3 approaches to the initial respiratory management of preterm neonates. Pediatrics 2011;128:e1069‐76. - PubMed
Finer 2006
    1. Finer NN, Merritt TA, Bernstein G, Job L, Mazela J, Liu G. A multicenter, pilot study of Aerosurf delivered via nasal CPAP to prevent RDS in pre‐term neonates. Proceeding of the 2006 Pediatric Academic Societies Annual Meeting. San Francisco, CA, USA, 2006:59:4840.138.
Flecknoe 2008
    1. Flecknoe SJ, Crossley KJ, Lane MA, Allison BJ, Morley CJ, Hooper SB. The effects of mechanical ventilation on airway epithelium in near term and very preterm sheep [Abstract]. Journal of Paediatrics and Child Health 2008;44(1):A42.
Fok 1998
    1. Fok TF, al Essa M, Dolovich M, Rasid F, Kirpalani H. Nebulisation of surfactant in an animal model of neonatal respiratory distress. Archives of Disease in Childhood Fetal Neonatal Edition 1998;78(1):F3‐9. - PMC - PubMed
Ghanta 2007
    1. Ghanta S, Abdel‐Latif ME, Lui K, Ravindranathan H, Awad A, Oei J. Propofol compared with the morphine, atropine, and suxamethonium regimen as induction agents for neonatal endotracheal intubation: a randomized, controlled trial. Pediatrics 2007;119(6):e1248‐55. - PubMed
Grossmann 1986
    1. Grossmann G, Nilsson R, Robertson B. Scanning electron microscopy of epithelial lesions induced by artificial ventilation of the immature neonatal lung; the prophylactic effect of surfactant replacement. European Journal of Pediatrics 1986;145(5):361‐7. - PubMed
Hellstrom‐Westas 1992
    1. Hellstrom‐Westas L, Bell AH, Skov L, Greisen G, Svenningsen NW. Cerebroelectrical depression following surfactant treatment in preterm neonates. Pediatrics 1992;89(4 Pt 1):643‐7. - PubMed
Higgins 2011
    1. Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org.
Ho 2002a
    1. Ho JJ, Subramaniam P, Henderson‐Smart DJ. Continuous distending pressure for respiratory distress syndrome in preterm infants. Cochrane Database of Systematic Reviews 2002, Issue 1. [DOI: 10.1002/14651858.CD002271] - DOI - PubMed
Ho 2002b
    1. Ho JJ, Henderson‐Smart DJ, Davis PG. Early versus delayed initiation of continuous distending pressure for respiratory distress syndrome in preterm infants. Cochrane Database of Systematic Reviews 2002, Issue 2. [DOI: 10.1002/14651858.CD002975] - DOI - PMC - PubMed
Hughes 1999
    1. Hughes CA, O'Gorman LA, Shyr Y, Schork MA, Bozynski ME, McCormick MC. Cognitive performance at school age of very low birth weight infants with bronchopulmonary dysplasia. Journal of Developmental and Behavioral Pediatrics 1999;20(1):1‐8. - PubMed
International Committee 2005
    1. International Committee for the Classification of Retinopathy of Prematurity. The international classification of retinopathy of prematurity revisited. Archives of Ophthalmology 2005;123:991‐9. - PubMed
Johnson 2006
    1. Johnson M, Mazela J, Pearson R, Rairkar M. KL4‐surfactant (Aerosurf) retains surface activity after aerosolization. 8th European Conference on Pediatric and Neonatal Ventilation. Montroux, Switzerland, 2006.
Johnson 2007
    1. Johnson ME, Rodriguez L, Pearson R, Rairkar M. KL4‐surfactant (Aerosurf) retains surface activity after aerosolization. Proceeding of the 2007 Pediatric Academic Societies' Annual Meeting. Toronto, Canada, 2007:751712.
Jorch 1994
    1. Jorch G, Weller E, Murlat A, Hentschel R. Feasibility study on nebulization of bovine surfactant by pharyngeal continuous positive airway pressure. Biology of the Neonate 1994;66:166.
Kamper 1999
    1. Kamper J. Early nasal continuous positive airway pressure and minimal handling in the treatment of very‐low‐birthweight infants. Biology of the Neonate 1999;76(Suppl 1):22‐8. - PubMed
Kattwinkel 2004
    1. Kattwinkel J, Robinson M, Bloom B, Delmore P, Ferguson JE. Technique for intrapartum administration of surfactant without requirement for an endotracheal tube. Journal of Perinatology 2004;24(6):360‐5. - PubMed
Kilbride 2003
    1. Kilbride HW, Gelatt MC, Sabath RJ. Pulmonary function and exercise capacity for ELBW survivors in preadolescence: effect of neonatal chronic lung disease. Journal of Pediatrics 2003;143(4):488‐93. - PubMed
Korhonen 1999
    1. Korhonen P, Koivisto AM, Ikonen S, Laippala P, Tammela O. Very low birthweight, bronchopulmonary dysplasia and health in early childhood. Acta Paediatrica 1999;88(12):1385‐91. - PubMed
Kribs 2007
    1. Kribs A, Pillekamp F, Hűsneler C, Vierzig A, Roth B. Early administration of surfactant in spontaneous breathing with nCPAP: feasibility and outcome in extremely premature infants (postmenstrual age </=27 weeks). Paediatric Anaesthesia 2007;17(4):364‐9. - PubMed
Kribs 2010
    1. Kribs A, Härtel C, Kattner E, Vochem M, Küster H, Möller J, et al. Surfactant without intubation in preterm infants with respiratory distress: first multi‐center data. Klinische Padiatrie 2010;222(1):13‐7. - PubMed
Kugelman 2007
    1. Kugelman A, Feferkorn I, Riskin A, Chistyakov I, Kaufman B, Bader D. Nasal intermittent mandatory ventilation versus nasal continuous positive airway pressure for respiratory distress syndrome: a randomized, controlled, prospective study. The Journal of Pediatrics 2007;150(5):521‐6. - PubMed
Lemyre 2002
    1. Lemyre B, Davis PG, Paoli AG. Nasal intermittent positive pressure ventilation (NIPPV) versus nasal continuous positive airway pressure (NCPAP) for apnea of prematurity. Cochrane Database of Systematic Reviews 2002, Issue 1. [DOI: 10.1002/14651858.CD002272] - DOI - PubMed
Lewis 1991
    1. Lewis JF, Ikegami M, Jobe AH, Tabor B. Aerosolized surfactant treatment of preterm lambs. Journal of Applied Physiology 1991;70(2):869‐76. - PubMed
Lewis 1993a
    1. Lewis JF, Tabor B, Ikegami M, Jobe AH, Joseph M, Absolom D. Lung function and surfactant distribution in saline‐lavaged sheep given instilled vs. nebulized surfactant. Journal of Applied Physiology 1993;74(3):1256‐64. - PubMed
Lewis 1993b
    1. Lewis JF, Ikegami M, Jobe AH, Absolom D. Physiologic responses and distribution of aerosolized surfactant (Survanta) in a nonuniform pattern of lung injury. American Review of Respiratory Disease 1993;147(6 Pt 1):1364‐70. - PubMed
Lewis 1993c
    1. Lewis J, McCaig L. Aerosolized versus instilled exogenous surfactant in a nonuniform pattern of lung injury. American Review of Respiratory Disease 1993;148(5):1187‐93. - PubMed
Majnemer 2000
    1. Majnemer A, Riley P, Shevell M, Birnbaum R, Greenstone H, Coates AL. Severe bronchopulmonary dysplasia increases risk for later neurological and motor sequelae in preterm survivors. Developmental Medicine and Child Neurology 2000;42(1):53‐60. - PubMed
Marshall 1984
    1. Marshall T, Deeder R, Pai S, Berkowitz GP, Austin TL. Physiologic changes associated with endotracheal intubation in preterm infants. Critical Care Medicine 1984;12(6):501‐3. - PubMed
Mazela 2007
    1. Mazela J, Merritt TA, Finer NN. Aerosolized surfactants. Current Opinion in Pediatrics 2007;19(2):155‐62. - PubMed
Morley 2008
    1. Morley CJ, Davis PG, Doyle LW, Brion LP, Hascoet J‐M, Carlin JB, COIN Trial Investigators. Nasal CPAP or intubation at birth for very preterm infants. New England Journal of Medicine 2008;358(7):700‐8. - PubMed
O'Reilly 2008
    1. O'Reilly M, Hooper SB, Allison BJ, Snibson K, Harding R, Sozo F. Airway remodeling and pulmonary inflammation in a model of ventilator‐induced injury of the very preterm lung [Abstract]. Journal of Paediatrics and Child Health 2008;44(1):A63.
Papile 1978
    1. Papile L‐A, Burstein J, Burstein R, Koffler H. Incidence and evolution of subependymal and intraventricular hemorrhages; a study of infants with birth weights less than 1500 grams. Journal of Pediatrics 1978;92:529‐34. - PubMed
Petrikovsky 1995
    1. Petrikovsky BM, Lysikiewicz A, Markin LB, Slomko Z. In utero surfactant administration to preterm human fetuses using endoscopy. Fetal Diagnosis and Therapy 1995;10(2):127‐30. - PubMed
Pfister 2007
    1. Pfister RH, Soll RF, Wiswell T. Protein containing synthetic surfactant versus animal derived surfactant extract for the prevention and treatment of respiratory distress syndrome. Cochrane Database of Systematic Reviews 2007, Issue 4. [DOI: 10.1002/14651858.CD006069.pub3] - DOI - PubMed
Pfister 2009
    1. Pfister RH, Soll R, Wiswell TE. Protein‐containing synthetic surfactant versus protein‐free synthetic surfactant for the prevention and treatment of respiratory distress syndrome. Cochrane Database of Systematic Reviews 2009, Issue 4. [DOI: 10.1002/14651858.CD006180.pub2] - DOI - PubMed
Reininger 2005
    1. Reininger A, Khalak R, Kendig JW, Ryan RM, Stevens TP, Reubens L, et al. Surfactant administration by transient intubation in infants 29 to 35 weeks' gestation with respiratory distress syndrome decreases the likelihood of later mechanical ventilation: a randomized controlled trial. Journal of Perinatology 2005;25(11):703‐8. - PubMed
RevMan 2011 [Computer program]
    1. The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.1. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2011.
Rojas‐Reyes 2012
    1. Rojas‐Reyes MX, Morley CJ, Soll R. Prophylactic versus selective use of surfactant in preventing morbidity and mortality in preterm infants. Cochrane Database of Systematic Reviews 2012, Issue 3. [DOI: 10.1002/14651858.CD000510.pub2] - DOI - PubMed
Sarkar 2006
    1. Sarkar S, Schumacher RE, Baumgart S, Donn SM. Are newborns receiving premedication before elective intubation?. Journal of Perinatology 2006;26(5):286‐9. - PubMed
Seger 2009
    1. Seger N, Soll R. Animal derived surfactant extract for treatment of respiratory distress syndrome. Cochrane Database of Systematic Reviews 2009, Issue 2. [DOI: 10.1002/14651858.CD007836] - DOI - PubMed
Shennan 1988
    1. Shennan AT, Dunn MS, Ohlsson A, Lennox K, Hoskins EM. Abnormal pulmonary outcomes in premature infants: prediction from oxygen requirement in the neonatal period. Pediatrics 1988;82(42):527‐32. - PubMed
Skidmore 1990
    1. Skidmore MD, Rivers A, Hack M. Increased risk of cerebral palsy among very low‐birthweight infants with chronic lung disease. Developmental Medicine and Child Neurology 1990;32(4):325‐32. - PubMed
Soll 1997
    1. Soll RF. Prophylactic animal derived surfactant extract for preventing morbidity and mortality in preterm infants. Cochrane Database of Systematic Reviews 1997, Issue 4. [DOI: 10.1002/14651858.CD000511] - DOI - PMC - PubMed
Soll 2000
    1. Soll RF. Synthetic surfactant for respiratory distress syndrome in preterm infants. Cochrane Database of Systematic Reviews 2000, Issue 2. [DOI: 10.1002/14651858.CD001149] - DOI - PMC - PubMed
Soll 2001
    1. Soll RF, Blanco F. Natural surfactant extract versus synthetic surfactant for neonatal respiratory distress syndrome. Cochrane Database of Systematic Reviews 2001, Issue 2. [DOI: 10.1002/14651858.CD000144] - DOI - PubMed
Soll 2009
    1. Soll R, Özek E. Multiple versus single doses of exogenous surfactant for the prevention or treatment of neonatal respiratory distress syndrome. Cochrane Database of Systematic Reviews 2009, Issue 4. [DOI: 10.1002/14651858.CD000141.pub2] - DOI - PubMed
Soll 2010
    1. Soll R, Ozek E. Prophylactic protein free synthetic surfactant for preventing morbidity and mortality in preterm infants. Cochrane Database of Systematic Reviews 2010, Issue 1. [DOI: 10.1002/14651858.CD001079.pub2] - DOI - PMC - PubMed
Stevens 2007
    1. Stevens TP, Blennow M, Myers EW, Soll R. Early surfactant administration with brief ventilation vs. selective surfactant and continued mechanical ventilation for preterm infants with or at risk for respiratory distress syndrome. Cochrane Database of Systematic Reviews 2007, Issue 2. [DOI: 10.1002/14651858.CD003063.pub3] - DOI - PMC - PubMed
SUPPORT Study Group 2010
    1. SUPPORT Study Group of the Eunice Kennedy Shriver NICHD Neonatal Research Network. Early CPAP versus surfactant in extremely preterm infants. New England Journal of Medicine 2010;362(21):1970‐9. - PMC - PubMed
Tooley 1987
    1. Tooley WH, Clements JA, Muramatsu K, Brown CL, Schlueter MA. Lung function in prematurely delivered rabbits treated with a synthetic surfactant. American Review of Respiratory Disease 1987;136(3):651‐6. - PubMed
Trevisanuto 2005
    1. Trevisanuto D, Grazzina N, Ferrarese P, Micaglio M, Verghese C, Zanardo V. Laryngeal mask airway used as a delivery conduit for the administration of surfactant to preterm infants with respiratory distress syndrome. Biology of the Neonate 2005;87(4):217‐20. - PubMed
van de Berg 2009
    1. Berg E, Lemmers PMA, Toet MC, Klaessens J, Bel F. The effect of the "InSurE" procedure on cerebral oxygenation and electrical brain activity of the preterm infant. Archives of Disease in Childhood Fetal and Neonatal Edition 2010;95:F53‐8. - PubMed
Van Marter 2000
    1. Marter LJ, Allred EN, Pagano M, Sanocka U, Parad R, Moore M, The Neonatology Committee and the Developmental Epidemiological Network. Do clinical markers of barotrauma and oxygen toxicity explain interhospital variation in rates of chronic lung disease? The Neonatology Committee for the Developmental Network. Pediatrics 2000;105(6):1194‐201. - PubMed
Verder 1994
    1. Verder H, Robertson B, Greisen G, Ebbesen F, Albertsen P, Lundstrom K, Danish‐Swedish Multicenter Study Group. Surfactant therapy and nasal continuous positive airway pressure for newborns with respiratory distress syndrome. Danish‐Swedish Multicenter Study Group. New England Journal of Medicine 1994;331(16):1051‐5. - PubMed
Victorin 1990
    1. Victorin LH, Deverajan LV, Curstedt T, Robertson B. Surfactant replacement in spontaneously breathing babies with hyaline membrane disease – a pilot study. Biology of the Neonate 1990;58(3):121‐6. - PubMed
Wolfson 2008
    1. Wolfson MR, Malone DJ, Wu J, Gregory TJ, Mazela J, Shaffer TH. Aerosurf delivery during CPAP improves lung mechanics and reduces inflammation in spontaneously breathing preterm lambs. Proceeding of the 2008 Pediatric Academic Societies Annual Meeting. Honolulu, Hawaii, USA, 2008 May 2‐6:P3763.19.
Yost 2000
    1. Yost CC, Soll RF. Early versus delayed selective surfactant treatment for neonatal respiratory distress syndrome. Cochrane Database of Systematic Reviews 2000, Issue 2. [DOI: 10.1002/14651858.CD001456] - DOI - PubMed
Young 2005
    1. Young KC, Moral T, Claure N, Vanbuskirk S. The association between early tracheal colonization and bronchopulmonary dysplasia. Journal of Perinatology 2005;25(6):403‐7. - PubMed

References to other published versions of this review

Abdel‐Latif 2010
    1. Abdel‐Latif ME, Osborn DA. Nebulised surfactant for prevention of morbidity and mortality in preterm infants with or at risk of respiratory distress syndrome (Protocol). Cochrane Database of Systematic Reviews 2010, Issue 1. [DOI: 10.1002/14651858.CD008310] - DOI

Publication types

MeSH terms

LinkOut - more resources